Oncotarget
The cover for issue 2 of Oncotarget features Supplementary Figure 4, "Using principal component analysis, distributions of subtypes in the Burstein et al. training set and our data set are shown," by Ding, et al.
The extended 4-year follow-up results of the ELOQUENT-2 trial |
https://doi.org/10.18632/oncotarget.26527 Maria Gavriatopoulou, Evangelos Terpos, and Meletios Athanasios Dimopoulos |
82-83 |
PDF | How to cite | Order a Reprint |
We shall overcome (drug resistance) some day |
https://doi.org/10.18632/oncotarget.26550 Geeta G. Sharma, and Luca Mologni |
84-85 |
PDF | How to cite | Order a Reprint |
AI for medical use |
https://doi.org/10.18632/oncotarget.26556 Masamitsu Konno, and Hideshi Ishii |
86-87 |
PDF | How to cite | Order a Reprint |
Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China |
https://doi.org/10.18632/oncotarget.26265 Jian Wang, Huiqin Li, Mingjuan Tan, Gu Gao, Ying Zhang, Bo Ding, Xiaofei Su, Xiaocen Kong, and Jianhua Ma |
88-97 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2 |
https://doi.org/10.18632/oncotarget.26414 J. Dinesh Kumar, Iman Aolymat, Laszlo Tiszlavicz, Zita Reisz, Hanan M. Garalla, Rob Beynon, Deborah Simpson, Graham J. Dockray, and Andrea Varro |
98-112 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies |
https://doi.org/10.18632/oncotarget.26451 Ashleigh C. McEvoy, Michelle R. Pereira, Anna Reid, Robert Pearce, Lester Cowell, Zeyad Al-Ogaili, Muhammad A. Khattak, Michael Millward, Tarek M. Meniawy, Elin S. Gray, and Melanie Ziman |
113-122 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells |
https://doi.org/10.18632/oncotarget.26498 Yousef G. Amaar, and Mark E. Reeves |
123-132 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility |
https://doi.org/10.18632/oncotarget.26512 Diva S. Whalen, Sarrah E. Widatalla, Olga Y. Korolkova, Gladys S. Nangami, Heather K. Beasley, Stephen D. Williams, Carlos Virgous, Brian D. Lehmann, Josiah Ochieng, and Amos M. Sakwe |
133-151 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers |
https://doi.org/10.18632/oncotarget.26520 Jyoti Roy, Miranda Kaake, and Philip S. Low |
152-160 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo |
https://doi.org/10.18632/oncotarget.26536 Kenta Watanabe, Yoshihiro Yui, Satoru Sasagawa, Kayo Suzuki, Masahiko Kanamori, Taketoshi Yasuda, and Tomoatsu Kimura |
161-174 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Photo-immune therapy with liposomally formulated phospholipid-conjugated indocyanine green induces specific antitumor responses with heat shock protein-70 expression in a glioblastoma model |
https://doi.org/10.18632/oncotarget.26544 Sayaka Shibata, Natsuki Shinozaki, Akiko Suganami, Shiro Ikegami, Yuki Kinoshita, Ryozo Hasegawa, Hirata Kentaro, Yoshiharu Okamoto, Ichio Aoki, Yutaka Tamura, and Yasuo Iwadate |
175-183 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion |
https://doi.org/10.18632/oncotarget.26546 Veronica S. Hughes, and Dietmar W. Siemann |
184-197 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity |
https://doi.org/10.18632/oncotarget.26559 Yuan Chun Ding, Linda Steele, Charles Warden, Sharon Wilczynski, Joanne Mortimer, Yuan Yuan, and Susan L. Neuhausen |
198-208 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis |
https://doi.org/10.18632/oncotarget.26541 Luigi Cavanna, Chiara Citterio, and Elena Orlandi |
209-215 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection |
https://doi.org/10.18632/oncotarget.26537 Muntasir Billah, Anisyah Ridiandries, Usaid Allahwala, Harshini Mudaliar, Anthony Dona, Stephen Hunyor, Levon M. Khachigian, and Ravinay Bhindi |
216-244 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma |
https://doi.org/10.18632/oncotarget.26521 Eric I. Marks, Sahithi Pamarthy, Don Dizon, Ari Birnbaum, Evgeny Yakirevich, Howard Safran, and Benedito A. Carneiro |
245-251 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors |
https://doi.org/10.18632/oncotarget.26575 Xiaoliang Zhao, Xiaohua Wen, Wei Wei, Yulong Chen, Jianquan Zhu, and Changli Wang |
252-252 |
Correction | PDF | How to cite |
Correction: Incidence and risk of regorafenib-induced hepatotoxicity |
https://doi.org/10.18632/oncotarget.26576 Bin Zhao, and Hong Zhao |
253-253 |
Correction | PDF | How to cite |
Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib |
https://doi.org/10.18632/oncotarget.26577 Bin Zhao, and Hong Zhao |
254-254 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC